OPTICALLY ACTIVE (R)-ARYLOXYPROPIONIC ACID AMIDES AND HERBICIDAL COMPOSITION COMPRISING SAME

FIELD OF THE INVENTION

The present invention relates to an optically active (R)-aryloxypropionic acid compound and a herbicidal composition comprising the same.

BACKGROUND OF THE INVENTION

There have been reported numerous compounds having herbicidal activity for weed control.

For example, United States Patent No. 4,130,413 discloses a compound of formula (II):

(H) wherein, A is O, S or NH; Ri is hydrogen, halogen, CF ₃ , NO ₂ , CN or alkyl; R ₂ is hydrogen or alkyl; Z is -CON-R ₉ R ₁₀ , R ₉ and Rj ₀ being each independently Ci _-6 alkyl, Ci _-6 hydroxyalkyl, C _3-6 cycloalkyl, Ci _-4 alkoxy or phenyl, substituted with 1 to 3 substituents selected from the group consisting of hydrogen, Cj _-4 alkyl, C]_ ₆ alkoxy, halogen and CF ₃ ; and m is O, 1 or 2 .

United States Patent No. 4,531,969 discloses a compound of formula (III):

wherein, R ₅ is , R ₆ being hydrogen or halogen, R ₇ being hydrogen or alkyl; Z is -CON-R ₉ R ₁₀ , R9 and R _]0 being each independently Ci _-6 alkyl,

C _1-6 hydroxyalkyl, C _3-6 cycloalkyl, C _1-4 alkoxy or phenyl, substituted with 1 to 3 substituents selected from the group consisting of hydrogen, Ci _-4 alkyl, Cj _-6 alkoxy, halogen and CF ₃ .

United States Patent No.5,254,527 discloses a compound of formula (IV):

wherein, R ₅ and Z have the same meanings as defined above. Japanese Laid-open Patent Publication No. Hei 2-11580 discloses a compound of formula (V).

wherein, L is low alkyl, halogen, methoxy, methoxyphenoxy, benzyloxy, methylthio or methylvinyl; n is 0 or 2.

The above-mentioned compounds are satisfactory in terms of selectivity and safety for desired crop plants, but not completely satisfactory for the weed control.

SUMMARY OF THE INVENTION

Accordingly, it is a primary object of the present invention to provide a novel compound, which has high selectivity and safety for protecting of crop plants such as rice, wheat, barley and soy bean, and exhibits excellent herbicidal activity against weeds, and a method for the preparation of said compound.

It is another object of the present invention to provide a herbicidal composition comprising said compound as an active ingredient.

In accordance with one aspect of the present invention, there is provided an optically active (R)-aryloxypropionic acid amide compound of formula (I):

(I) wherein,

A is fluorophenylvinyl, cyanofluorophenyl or chlorobenzoxazolyl, optionally substituted with one or more substituents each independently selected from the group consisting of CF ₃ , halogen and C^ alkyl;

D is fluorophenyl, benzoxazolyl, benzothiazolyl, benzimidazolyl, pyrazolyl, pyridinyl, pyrazinyl or thiazolyl, optionally substituted with one or more substituents each independently selected from the group consisting of halogen, Ci^ alkyl and Ci _-4 alkoxy, with the proviso that when A is chlorobenzoxazolyl, D is not fluorophenyl; and

Ri is hydrogen or C _1-4 alkyl.

DETAILED DESCRIPTION OF THE INVENTION

Among the compounds of formula (I) of the present invention, preferred are those wherein:

A is l-fluoro-2-phenylvinyl, l-fluoro-2-(4-fluorophenyl)vinyl,

1 ,3,3,3-tetrafluoro-2-phenylpropen- 1 -yl,

1 ,3 ,3 ,3-tetrafluoro-2-(4-fluorophenyl)propen- 1 -yl, 1 -fluoro-2-(4-methylphenyl)vinyl, 1 -fluoro-2-(4-chlorophenyl)vinyl, 1 ,3,3,3-tetrafluoro-2-(4-chlorophenyl)propen- 1 -yl, 6-chlorobenzoxazolyl or 4-cyano-2-fluorophenyl;

D is 2-fluorophenyl, 5-chloro-2-benzoxazolyl, l-methyl-2-benzimidazolyl, 2-benzthiazolyl, 6-chloro-2-benzthiazolyl, 6-fluoro-2-benzthiazolyl,

6-methyl-2-benzthiazolyl, 6-methoxy-2-benzthiazolyl, 5-chloro-2-benzoxazolyl, l,3-dimethyl-5-pyrazolyl, 2-thiazolyl, 4-methyl-2-pyridinyl, 2-pyrazinyl or 5-chloro-2-pyridinyl, with the proviso that when A is chlorobenzoxazolyl, D is not fluorophenyl; and

Ri is hydrogen or methyl.

More preferred compounds of formula (I) according to the present invention are:

( 1 ) (7? _y ⁾ -2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-N-(5-chloro-2-benzoxazoryl)amide;

(2) (7?j-2-[4-(6-chloro-2-benzoxazoryloxy)phenoxy]propionic acid-N-(5-chloro-2-benzoxazolyl)-N-methyl amide;

(3) fR)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy propionic acid-λ ^r -(l-methyl-2-benzimidazolyl)amide;

(4) ^)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-N-(l -methyl-2-benzimidazolyl)-N-methyl amide;

(5) f _J Rj-2-[4-(6-chloro-2-benzoxazolyloxy)pb.enoxy]propionic acid-N-(2-benzothiazolyl)amide;

(6) (R)-2- [4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-N-(2-benzothiazolyl)-λ ^r -methyl amide;

(7) (fy-2- [4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-N-(6-chloro-2-benzothiazolyl)amide;

(8) (R,)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-N-(6-chloro-2-benzothiazolyl)-N-methyl amide;

(9) (R)-2- [4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-N-(6-fluoro-2-benzothiazolyl)amide;

(10) (R)-2- [4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid- _J N-(6-fluoro-2-benzothiazolyl)-λ/-methyl amide;

(11) (R)-2- [4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-N-(6-methyl-2-benzothiazolyl)amide;

(12) (R)-2- [4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-N-(6-methyl-2-benzothiazolyl)-N-methyl amide;

(13) (RJ-2- [4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-N-(6-methoxy-2-benzothiazolyl)amide;

(14) fRJ-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-N-(6-methoxy-2-benzothiazolyl)-N-methyl amide;

(15) CR _y )-2-[4-(4-cyano-2-fluorophenoxy)phenoxy]propionic

acid-N-(5-chloro-2-benzoxazolyl)amide;

( 16) (7?^-2-[4-(4-cyano-2-fluorophenoxy)phenoxy]propionic acid-N-(5-chloro-2-benzoxazolyl)-jV-methyl amide;

(17) (R)-Z- [4-(4-cyano-2-fluorophenoxy)phenoxy]propionic acid-N-( 1 -methyl-2-benzimidazolyl)amide;

(18) ^-2-[4-(4-cyano-2-fluorophenoxy)phenoxy]propionic acid-N-( 1 -methyl-2-benzimidazolyl)-N-methyl amide;

(19) ^R _/ )-2-[4-(4-cyano-2-fluorophenoxy)phenoxy]propionic acid-7V-(2-benzothiazolyl)amide;

(20) (R)-Z- [4-(4-cy ano-2-fluorophenoxy)phenoxy]propiθEic acid-7V-(2-benzothiazolyl)-N-methyl amide;

(21) f7?>-2-[4-(4-cyano-2-fluorophenoxy)phenoxy]propionic acid-N-(6-chloro-2-benzothiazolyl)amide;

(22) (R)-Z- [4-(4-cyano-2-fluorophenoxy)phenoxy]propionic acid-N-(6-chloro-2-benzothiazolyl)-λ ^r -tnethyl amide;

(23) fϊ?J-2-[4-(4-cyano-2-fluorophenoxy)phenoxy]propionic acid-N-(6-fluoro-2-benzothiazolyl)amide;

(24) (R)-Z- [4-(4-cyano-2-fluorophenoxy)phenoxy]propionic acid-N-(6-fluoro-2-benzothiazolyl)-iV ^: methyl amide;

(25) (7?,)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy]propionic acid-N-(6-methyl-2-benzothiazolyl)amide;

(26) CRJ-2-[4-(4-cyano-2-fluorophenoxy)phenoxy]propionic acid-N-(6-methyl-2-benzothiazolyl)-N-methyl amide;

(27) (R)-2~ [4-(4-cyano-2-fluorophenoxy)phenoxy]propionic acid-N-(6-methoxy-2-benzothiazolyl)amide;

(28) (7?^-2-[4-(4-cyano-2-fluorophenoxy)phenoxy]propionic acid-N-(6-methoxy-2-benzothiazolyl)-N-methyl amide;

(29) (R)-Z- [4-(4-cyano-2-fluorophenoxy)phenoxy]propionic acid-N-(l,3-dimethyl-5-pyrazolyl)amide;

(30) f7?j-2-[4-(4-cyano-2-fluorophenoxy)phenoxy]propionic acid-N-( 1 ,3-dimethyl-5-pyrazolyl)-N-methyl amide;

(31) fi?j-2-[4-(4-cyano-2-fluorophenoxy)phenoxy]propionic acid-N-(2-thiazolyl)amide;

(32) (7^-2-[4-(4-cyano-2-fluorophenoxy)phenoxy]propionic acid-N-(2-thiazolyl)-N-methyl amide;

(33) (7? _> )-2-[4-(4-cyano-2-fluorophenoxy)phenoxy]propiomc acid-N-(4-methyl-2-pyridinyl)amide;

(34) (R)-2- [4-(4-cyano-2-fluorophenoxy)phenoxy]propionic acid-N-(4-methyl-2-pyridinyl)-N-methyl amide;

(35) (R)-2- [4-(4-cyano-2-fluorophenoxy)phenoxy]propionic acid-N-(2-pyrazinyl)amide;

(36) (Rj-2-[4-(4-cyano-2-fluorophenoxy)phenoxy]propionic acid-N-(2-pyrazinyl)-N-methyl amide;

(37) (ϊ?j-2-[4-(l-fluoro-2-phenylvinyloxy)phenoxy]propionic acid-N-(2-fluorophenyl)-N-methyl amide;

(38) CRj-2-[4-(l-fluoro-2-phenylvinyloxy)phenoxy]propionic acid-N-(2-fluorophenyl)amide;

(39) (R)-2-[4-(l-fluoro-2-(4-fluorophenyl)vinyloxy)phenoxy]propio nic acid-N-(2-fluorophenyl)amide;

(40) fR>2-[4-(l,3,3,3-tetrafluoro-2-(4-fluorophenyl)prop-l-eny l)phenoxy] propionic acid-N-(2-fluorophenyl)amide;

(41) (R)-2-[4-( 1 -fluoro-2-(4-methylphenyl)vinyloxy)phenoxy]propionic acid-N-(2-fluorophenyl)amide;

(42) (7?^-2-[4-(l,3,3,3-tetrafluoro-2-phenylprop-l-enyl)phenoxy]p ropionic acid-N-(2-fluorophenyl)amide;

(43) f?? _y )-2-[4-(l-fluoro-2-(4-chlorophenyl)vinyloxy)phenoxy]propioni c acid-N-(2-fluorophenyl)amide;

(44) (R)-2- [4-( 1 ,3 ,3 ,3 -tetrafluoro-2-(4-chlorophenyl)prop- 1 -enyl)phenoxy] propionic acid-N-(2-fluorophenyl)-N-methyl amide;

(45) ( ^< R _y )-2-[4-(l-fluoro-2-(4-fluorophenyl)vinyloxy)phenoxy]propioni c acid-N-(2-fluorophenyl)-N-methyl amide;

(46) CR>2-[4-(l ,3,3,3-tetrafluoro-2-(4-flυorophenyl)prop- l-enyl)phenoxy]

propionic acid-τV-(2-fluorophenyl)-N-methyl amide;

(47) (R)-I- [4-( 1 -fluoro-2-(4-methylphenyl)vinyloxy)phenoxy]propionic acid-N-(2-fluorophenyl)-N-methyl amide;

(48) ^-2-[4-(1 ,3,3,3-tetrafluoro-2-phenylprop- 1 -enyl)phenoxy]propionic acid-N-(2-fluorophenyl)-N-methyl amide;

(49) (R)-2-[4-( 1 -fluoro-2-(4-chlorophenyl)vinyloxy)phenoxy]propionic acid-N-(2-fluorophenyl)-N-methyl amide;

(50) (R)-I- [4-( 1 ,3 ,3 ,3-tetrafluoro-2-(4-chlorophenyl)prop- 1 -enyl)phenoxy] propionic acid-N-(2-fluorophenyl)-N-methyl amide;

(51) (R)-2-[4-( 1 -fluoro-2-phenylvinyloxy)phenoxy]propionic acid-N-(5-chloro-2-benzoxazolyl)amide;

(52) f7?j-2-[4-(l-fluoro-2-(4-fluorophenyl)vinyloxy)phenoxy]propi onic acid-N-(5-chloro-2-benzoxazolyl)amide;

(53) fϊ?j-2-[4-(l,3,33-tetrafluoro-2-(4-fluorophenyl)prop-l-enyl )phenoxy] propionic acid-N-(5-chloro-2-benzoxazolyl)amide;

(54) (R)-2- [4-( 1 -fluoro-2-(4-methylphenyl)vinyloxy)phenoxy]propionic acid-N-(5-chloro-2-benzoxazolyl)amide;

(55) (R)-2-[4-(l ,3,3,3-tetrafluoro-2-phenylprop- l-enyl)phenoxy]propionic acid-N-(5-chloro-2-benzoxazolyl)amide;

(56) (7?^-2-[4-(l-fluoro-2-(4-chlorophenyl)vinyloxy)phenoxy]propi onic acid-N-(5-chloro-2-benzoxazolyl)amide;

(57) (R)-2-[4-(l ,3,3,3-tetrafluoro-2-(4-chlorophenyl)proρ- l-enyl)phenoxy] propionic acid-.N-(5-chloro-2-benzoxazolyl)amide;

(58) (R)-2- [4-( 1 -fluoro-2-phenylvinyloxy)phenoxy]propionic acid-N-(5-chloro-2-benzoxazolyl)-N-methyl amide;

(59) (7? _> )-2-[4-(l-fluoro-2-(4-fluorophenyl)vinyloxy)phenoxy]propioni c acid-N-(5-chloro-2-benzoxazolyl)-N-methyl amide;

(60) (R)-2-[4-(l ,3,3,3-tetrafluoro-2-(4-fluorophenyl)prop- 1 -enyl)phenoxy] propionic acid-N-(5-chloro-2-benzoxazolyl)-N-methyl amide;

(61) (7?j-2-[4-(l-fluoro-2-(4-methylphenyl)vinyloxy)phenoxy]propi onic acid-N-(5-chloro-2-benzoxazolyl)-N-methyl amide;

(62) (R)-2-[4-( 1 ,3 ,3 ,3-tetrafluoro-2-phenylprop- 1 -enyl)phenoxy]propionic acid-N-(5-chloro-2-benzoxazolyl)-N-methyl amide;

(63) (R)-2- [4-( 1 -fluoro-2-(4-chlorophenyl)vinyloxy)phenoxy]propionic acid-N-(5-chloro-2-benzoxazolyl)-N-methyl amide; and

(64) CR>2-[4-(l,3,3,3-tetrafluoro-2-(4-chlorophenyl)proρ-l-en yl)phenoxy] propionic acid-iV-(5-chloro-2-benzoxazolyl)-N-methyl amide.

The inventive compound of formula (I) may be prepared by subjecting a compound of formula (VI) to a reaction with a compound of formula (VII) in accordance with a conventional method:

wherein,

A, D and R ₁ have the same meanings as defined above; and

E is OH, Cl, Br or phenoxy.

The compounds of formula (VI) and formula (VII) are commercially available, or they may be prepared by conventional methods. In the above reaction, the compound of formula (VI) and the compound of formula (VII) may be employed in a mole ratio ranging from 1 :1 to 3, preferably ranging from 1 :1 to 1.2. This reaction may be carried out at a temperature ranging from -10 ^° C to 100 ^° C in the presence of an organic base such as triethylamine and pyridine. In this reaction, the organic base

may be preferably diluted with a solvent such as ethylacetate, acetonitrile, toluene, xylene, hexane, cyclohexane, methylene chloride, dichloroethane and tetrahydrofurane. After completion of the reaction, the solvent is removed from the reaction mixture and the resulting residue is subjected to column chromatography to obtain the inventive compound of formula (I).

Alternatively, the compound of formula (I) may be obtained by subjecting a compound of formula (VIII) to a reaction with a compound of formula (IX):

(I)

(VIII)

A-R ₃

(IX) wherein,

A, D and Ri have the same meanings as defined above; and

R ₃ is hydrogen, halogen or Ci _-4 alkyl.

The compounds of formula (VIII) and formula (IX) are commercially available, or they may be prepared by a conventional method. In the above reaction, the compound of formula (VIII) and the compound of formula (IX) may be employed in a mole ratio ranging from 1 :1 to 3, preferably ranging from 1 :1 to 1.2. This reaction may be carried out at a temperature ranging from 20 ^° C to 150 ^° C in the presence of an organic base such as triethyl amine and pyridine, or an inorganic base such as sodium hydroxide, potassium carbonate and sodium carbonate. In this reaction, the organic or inorganic base may be preferably diluted with a solvent such as ethylacetate, acetonitrile, toluene, xylene, hexane, cyclohexane, methylene chloride, dichloroethane and tetrahydrofurane. After completion of the reaction, the solvent is removed from the reaction mixture and the resulting residue is subjected to column

chromatography to obtain the inventive compound of formula (I).

In accordance with further aspect of the present invention, the present invention provides a herbicidal composition comprising the compound of formula (I) as an active ingredient.

The inventive herbicidal composition may be formulated in various forms such as a wettable powder, an emulsion, granules, water-dispersible granules, a microemulsion, a suspension and a liquid, which may be prepared by mixing the compound of formula (I) with conventional additives used in the agricultural formulation. Representative examples of the additives include polyoxyethylene alkyl sulfate, polyoxyethylene alkyl phenyl sulfate, alkyl aryl sulfonate, alkenyl sulfonate, higher fatty acid, alkyl taurinate, dialkyl sulphosuccinate, polyoxyethylene alkyl ether, xanthan gum, polyoxyethylene alkylphenyl ether, polyoxyethylene styrylphenyl ether and a mixture thereof. Such formulations may be diluted using conventional diluents, if necessary. Representative examples of the diluents used in the present invention include clay minerals such as agalmatolite, talc, kaoline, clay, calcium carbonate, bentonite, silicic acid, silica powder, diatomite, gypsum, pumice and a mixture thereof. Representative examples of the solvent used in the present invention include xylene, cyclohexanone, methylnaphthalene,

N-methyl-2-pyrrolidone, water and a mixture thereof.

The formulations comprise the active ingredient in an amount ranging from 0.1 to 99 % by weight. The preferred amounts of each of the component contained in the formulations according to the formulation forms are shown in Table 1.

Table 1

The formulation may further comprise trace amounts of conventional additives for preventing the formation of foam, caking, corrosion and the microbial growth.

In accordace with the present invention, a liquid, an emulsion or a microemulsion may be readily obtained by mixing the active ingredient with the additives; a wettable powder may be obtained by grinding the mixture using a hammer mill or air mill; and water-dispersible granules may be obtained by mixing the wettable powder together with additives and extruding the mixture. Further, a suspension may be obtained by grinding the mixture using a wet mill; and granules may be obtained by mixing or extruding the active ingredients with a solid diluent, or spraying the active ingredient on a carrier.

A proposed dosage of the inventive compound used as an active ingredient in the herbicide is about from 10g/ha to 1 kg/ha, more preferably about from 50g/ha to 400g/ha. It should be understood that the dosage should be determined in light of various relevant factors including the amount of weed occurrence, the stage of plant development and the form of formulation, and, therefore, the dosage suggested above should not be construed to limit the scope of the invention in anyway.

The inventive herbicide can be combined with other herbicides, insecticides and fungicides. In addition, the inventive herbicide may be combined with bensulfuronmethyl, pyrazosulfuronethyl, imazosulfuronmethyl, halosulfuronmethyl,

azimsulfuron, bentazone, quinclorac, propanyl, 2,4-D, linuron, MCPA(2-methyl-4-chlorophenoxy acetic acid), azafenidine, carfentrazone, molinate, mefenacet, thiobencarb, pretilachlor, trifluralin, brooxynyl, butachlor, mecoprop, metribuzin, bifenox, cyhalofopbutyl, fentrazamide, pyriminobac methyl, bispyribac sodium, cyclosulfamuron and a mixture thereof.

The following Examples are intended to further illustrate the present invention without limiting its scope.

Example 1: Preparation of (λ)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy] propionic acid-7V-(5-chloro-2-benzoxazolyl)amide

(1-1): (l?)-2-(4-hydroxyphenoxy)propionic acid-iV-(5-chloro-2-benzoxazolyl) amide

4.Og (0.022mol) of (R)-2-(4-hydroxyphenoxy)propionic acid was dissolved in 25ml of thionyl chloride, the mixture was refluxed for 5 hours, and distilled under a reduced pressure. 3.3g (0.016mol) of (R)-2-(4-hydroxyphenoxy)propionic acid chloride thus obtained was dissolved in 60 ml of tetrahydrofuran, and the mixture was cooled to 0 ^° C . 3.04g (0.018mol) of 2-amino-5-chlorobenzoxazole and triethylamine dissolved in 15 ml of tetrahydrofuran were sequentially added to the reaction mixture. The mixture was stirred at room temperature for 5 hours, and the solvent was removed therefrom under a reduced pressure. After adding water thereto, the mixture was extracted three times with ethyl acetate three times. The combined organic layer was dried over anhydrous magnesium sulfate, filtered and distilled under a reduced pressure. The resulting residue was subjected to column chromatography (ethyl acetate: n-hexane = 1 : 4) to obtain the title compound (4.04g, 75.9 %). 1H-NMR(CDCl ₃ ) : δl.6(3H, d), 4.68(1H, q), 6.6 ~6.7(4H, m), 7.1 ~7.2(3H, m), 8.13(lH, s)

(1-2): (i?)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-7V-(5-chloro -2-benzoxazolyl)amide

A mixture of 1.6g (4.8mmol) of the compound obtained in (1-1), l.lOg (5.7mmol) of 2,6-dichlorobenzoxazole, and 0.72g (5.7mmol) of potassium carbonate was added in 80ml of acetonitrile, and the mixture was reflexed for 7 hours. The resulting mixture was cooled to room temperature and filtered to remove unreacted solid therefrom, and the filtrate was distilled under a reduced pressure. The resulting residue was subjected to column chromatography (ethyl acetate: n-hexane = 1 : 4) to obtain the title compound (1.88g, 80.9 %). 1H-NMR(CDCl ₃ ) : δl.70(3H, d), 4.91(1H, q), 7.02 ~7.60(10H, m), 9.19(1H, s)

Example 2: Preparation of (i?)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy] propionic acid-λ^-(5-chloro-2-benzoxazolyl)-λ ^r -methyl amide

0.48g (lmmol) of the compound obtained in Example (1-2) was dissolved in anhydrous tetrahydrofuran, and the mixture was cooled to 0 ^° C . 40mg (lmmol) of 60% NaH and 0.14g (lmmol) of methyliodide were sequentially added to the reaction mixture and the mixture was stirred at room temperature for 5 hours. Ice was added to the reaction mixture and resulting mixture was extracted three times with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, filtered and distilled under a reduced pressure. The resulting residue was subjected to column chromatography (ethyl acetate: n-hexane = 1 : 2) to obtain the title compound (345mg, 71.9 %). 1H-NMR(CDCl ₃ ) : δl.70(3H, d), 3.84(3H, s), 4.91(1H, q), 7.02 ~ 7.60(1OH, m)

Example 3: Preparation of (/?)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy] propionic acid-7V-(l-methyl-2-benzimidazolyl)amide

(3-1): (jR)-2-(4-hydroxyphenoxy)propionic acid-7V-(l-methyl-2-benzimidazolyl) amide

The procedure of Example (1-1) was repeated except for using 2-amino-l-methylbenzimidazole(2.65g, O.Olδmol) instead of

2-amino-5-chlorobenzoxazole to obtain the title compound (3.98g, 71 %).

¹ H-NMR(CDCl ₃ ) : δl.7(3H, d), 3.65(3H, s), 4.68(1H, q), 6.9 ~7.1(4H, m), 7.25 ~7.41(4H, m), 12.03(1H, s)

(3-2): (i?)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-7V-(l-methyl -2-benzimidazolyl)amide

The procedure of Example (1-2) was repeated except for using (R)-2-(4-hydroxyphenoxy)propionic acid-N-(l-methyl-2-benzimidazolyl)amide(1.5g, 4.8mmol) obtained in (3-1) instead of (/?)-2-(4-hydroxyphenoxy)propionic acid-N-(6-chloro-2-benzoxazolyl)amide to obtain the title compound (1.83g, 82.4 %). 1H-NMR(CDCl ₃ ) : δl.7(3H, d), 3.65(3H, s), 4.68(1H, q), 7.02 ~7.41(l lH, m), 12.01(1H, s)

Example 4: Preparation of (/?)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy] propionic acid-iV-(l-methyl-2-benzimidazolyl)-JV-metb.yl amide

The procedure of Example 2 was repeated except for using (R)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-N-(l-methyl-2-benzirnidazolyl)amide(0.46g, lmmol) obtained in Example (3-2) instead of (R)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-N-(5-chloro-2-benzoxazolyl)amide to obtain the title compound (305mg, 64.5 %).

¹ H-NMR(CDCl ₃ ) : δl.70(3H, d), 3.65(3H, s), 3.84(3H, s), 4.91(1H, q), 7.02 ~ 7.41(1OH, m)

Example 5: Preparation of (J?)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy] propionic acid-7V-(2-benzothiazolyI)amide

(5-1): (J?)-2-(4-hydroxyphenoxy)propionic acid-λ ^/ -(2-benzothiazolyl)amide

The procedure of Example (1-1) was repeated except for using 2-aminobenzothiazole(2.72g, O.Olδmol) instead of 2-amino-5-chlorobenzoxazole to

obtain the title compound (4.61g, 81.5 %).

¹ H-NMR(CDCl ₃ ) : δl.7(3H, d), 4.68(1H, q), 6.6~6.7(4H, m), 7.1 ~7.2(3H, m),

8.13(1H, s)

(5-2): (/?)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-iV-(2- benzothiazolyl)amide

The procedure of Example (1-2) was repeated except for using (R)-2-(4-hydroxyphenoxy)propionic acid-N-(2-benzothiazolyl)amide( 1.5g, 4.8mmol) obtained in (5-1) instead of (R)-2-(4-hydroxyphenoxy)propionic acid-N-(6-chloro-2-benzoxazolyl)amide to obtain the title compound (1.84g, 82.3 %). 1H-NMR(CDCl ₃ ) : δl.73(3H, d), 4.96(1H, q), 7.03 ~7.88(10H, m), 9.83(1H, s)

Example 6: Preparation of (J?)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy] propionic acid-JV-(2-benzothiazolyl)-JV-methyl amide

The procedure of Example 2 was repeated except for using (R)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-N-(2-benzothiazolyl)amide(0.47g, lmmol) obtained in Example (5-2) instead of (R)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-N-(5-chloro-2-benzoxazolyl)amide to obtain the title compound (355mg, 74 %). ¹ H-NMR(CDCl ₃ ) : δl.73(3H, d), 3.65(3H, s), 4.91(1H, q), 7.02 ~ 7.88(1OH, m)

Example 7: Preparation of (J?)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy] propionic acid-7V-(6-chloro-2-benzothiazolyl)amide

(7-1): (λ)-2-(4-hydroxyphenoxy)propionic acid-λ^-(6-chloro-2-benzothiazolyl) amide

The procedure of Example (1-1) was repeated except for using (2-amino-6-chlorobenzothiazole(3.3g, O.Olδmol) instead of

2-amino-5-chlorobenzoxazole to obtain the title compound (4.15g, 66.1 %). 1H-NMR(CDCl ₃ ) : δl.7(3H, d), 4.68(1H, q), 6.6 ^~ 6.8(4H, m), 7.56 ~ 8.14(3H, m),

9.68(1H, s)

(7-2): (λ)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-jV-(6-chloro- 2-benzothiazolyl)amide

The procedure of Example (1-2) was repeated except for using (R)-2-(4-hydroxyphenoxy)propionic acid-N-(6-chloro-2-benzothiazolyl)amide( 1.67g, 4.8mmol) obtained in (7-1) instead of (R)-2-(4-hydroxyphenoxy)propionic acid-N-(6-chloro-2-benzoxazolyl)amide to obtain the title compound (1.64g, 68.3 %). 1H-NMR(CDCl ₃ ) : δl.68(3H, d), 4.91(1H, q), 6.73 ~7.79(10H, m), 9.7O(1H, s)

Example 8: Preparation of (jR)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy] propionic acid-7V-(6-chloro-2-benzothiazolyl)-λ ^r -methyl amide

The procedure of Example 2 was repeated except for using (R)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-N-(6-chloro-2-benzothiazolyl)amide(0.5g, lmmol) obtained in Example (7-2) instead of (R)-2- [4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-N-(5-chloro-2-benzoxazolyl)amide to obtain the title compound (360mg, 70 %). ¹ H-NMR(CDCl ₃ ) : δl.68(3H, d), 3.64(3H, s), 4.91(1H, q), 6.92 ~7.78(10H, m)

Example 9: Preparation of (J?)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy] propionic acid-7V-(6-fluoro-2-benzothiazolyl)amide

(9-1): (/?)-2-(4-hydroxyphenoxy)propionic acid-7V-(6-fluoro-2-benzothiazoIyl) amide

The procedure of Example (1-1) was repeated except for using 2-amino-6-fluorobenzothiazole(3.03g, 0.018mol) instead of

2-amino-5-chlorobenzoxazole to obtain the title compound (4.78g, 79.9 %). 1H-NMR(CDCl ₃ ) : δl.7(3H, d), 4.68(1H, q), 6.6 ~6.9(4H, m), 7.26 ~8.2(3H, m), 9.68(1H, s)

(9-2): (7?)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-iV-(6-fluoro -2-benzothiazolyl)amide

The procedure of Example (1-2) was repeated except for using (R)-2-(4-hydroxyphenoxy)propionic acid-N-(6-fluoro-2-benzothiazolyl)amide( 1.6Og, 4.8mmol) obtained in (9-1) instead of (R)-2-(4-hydroxyphenoxy)propionic acid-N-(6-chloro-2-benzoxazolyl)amide to obtain the title compound (1.93g, 83.1 %). 1H-NMR(CDCl ₃ ) : δl.69(3H, d), 4.93(1H, q), 6.73 ~7.74(10H, m), 9.84(1H, s)

Example 10: Preparation of (/?)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy] propionic acid-λ ⁷ -(6-fluoro-2-benzothiazolyl)-λ ^r -methyl amide

The procedure of Example 2 was repeated except for using (R)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-N-(6-fluoro-2-benzothiazolyl)amide(0.49g, lmmol) obtained in Example (9-2) instead of (R)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-N-(5-chloro-2-benzoxazolyl)amide to obtain the title compound (350mg, 69.3 %).

¹ H-NMR(CDCl ₃ ) : δl.68(3H, d), 3.64(3H, s), 4.91(1H, q), 6.72 ~ 7.78(1OH, m)

Example 11: Preparation of (λ)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy] propionic acid-iV-(6-inethyl-2-benzothiazolyl)amide

(11-1): (λ)-2-(4-hydroxyphenoxy)propionic acid-7V-(6-methyI-2-benzothiazolyl) amide

The procedure of Example (1-1) was repeated except for using 2-amino-6-methylbenzothiazole(2.96g, O.Olδmol) instead of

2-amino-5-chlorobenzoxazole to obtain the title compound (4.91g, 83.1 %). 1H-NMR(CDCl ₃ ) : δl.7(3H, d), 2.44(3H, s), 4.89(1H, q), 6.6 ~6.9(4H, m), 7.35 ~ 8.01(3H, m), 9.71(1H, s)

(11-2): (λ)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-λ'-(6- methyl-2-benzothiazolyl)amide

The procedure of Example (1-2) was repeated except for using (R)-2-(4-hydroxyphenoxy)propionic acid-N-(6-methyl-2-benzothiazolyl)amide( 1.58g, 4.8mmol) obtained in (11-1) instead of (i?)-2-(4-hydroxyphenoxy)propionic acid-N-(6-chloro-2-benzoxazolyl)amide to obtain the title compound (1.87g, 81.2 %). 1H-NMR(CDCl ₃ ) : δl.69(3H, d), 2.44(3H, s), 4.89(1H, q), 6.95 ~7.65(10H, m), 9.71(1H, s)

Example 12: Preparation of (i?)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy] propionic acid-iV-(6-methyl-2-benzothiazolyl)-/V-methyl amide

The procedure of Example 2 was repeated except for using (R)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-N-(6-methyl-2-benzothiazolyl)amide(0.48g, lmmol) obtained in Example (11-2) instead of (^)-2- [4-(6-chloro-2-benzoxazolyloxy)phenoxy]prop ionic acid-N-(5-chloro-2-benzoxazolyl)amide to obtain the title compound (323mg, 65.3 %).

¹ H-NMR(CDCl ₃ ) : δl.68(3H, d), 2.44(3H, s), 3.64(3H, s), 4.91(1H, q), 6.72-7.78(10H, m)

Example 13: Preparation of (J?)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy] propionic acid-7V-(6-methoxy-2-benzothiazolyl)amide

(13-1): (/?)-2-(4-hydroxyphenoxy)propionic acid-7V-(6-methoxy-2-benzothiazolyl) amide

The procedure of Example (1-1) was repeated except for using 2-amino-6-methoxybenzothiazole(3.25g, O.Olδmol) instead of

2-amino-5-chlorobenzoxazole to obtain the title compound (5.05g, 81.5 %). 1H-NMR(CDCl ₃ ) : δl .7(3H, d), 3.87(3H, s), 4.89(1H, q), 6.6 ~6.9(4H, m), 7.35 ~ 8.01(3H. m), 9.71(lH, s)

(13-2): (λ)-2-[4-(6-chIoro-2-benzoxazolyloxy)phenoxy]propionic acid-iV-(6- methoxy-2-benzothiazolyl)amide

The procedure of Example (1-2) was repeated except for using (R)-2-(4-hydroxyphenoxy)propionic acid-λ ^L (6-methoxy-2-benzothiazolyl)amide(1.58g, 4.8mmol) obtained in (13-1) instead of (i?)-2-(4-hydroxyphenoxy)propionic acid-N-(6-chloro-2-benzoxazolyl)amide to obtain the title compound (2.09g, 87.8 %). 1H-NMR(CDCl ₃ ) : δl.67(3H, d), 3.87(3H, s), 4.92(1H, q), 7.02 ~7.44(l OH, m), 9.73(1H, s)

Example 14: Preparation of (/?)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy] propionic acid-λ ^r -(6-methoxy-2-benzothiazolyl)-7V-methyl amide

The procedure of Example 2 was repeated except for using (R)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-N-(6-methoxy-2-benzothiazolyl)amide(0.5g, lmmol) obtained in Example (13-2) instead of (R)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-N-(5-chloro-2-benzoxazolyl)amide to obtain the title compound (368mg, 71.5 %).

¹ H-NMR(CDCl ₃ ) : δl.68(3H, d), 3.64(3H, s), 3.87(3H, s), 4.91(1H, q), 6.72 ~ 7.46(1OH, m)

Example 15: Preparation of (/?)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy] propionic acid-iV-(5-chIoro-2-benzoxazolyl)ainide

A mixture of 1.6g (4.8mmol) of the compound obtained in Example (1-1), 0.8g (5.7mmol) of 3,4-difluorobenzonitrile and 0.72g (5.7mmol) of potassium carbonate was added in 100ml of acetonitrile, and the mixture was reflexed for 7 hours. The mixture was cooled to room temperature and filtered to remove unreacted solid therefrom, and the filtrate was distilled under a reduced pressure.

The resulting residue was subjected to column chromatography (ethyl acetate: n-hexane = 1 : 4) to obtain the title compound (1.83g, 84.4 %). 1H-NMR(CDCl ₃ ) : δl.72(3H, d), 4.88(1H, q), 6.88 ~7.59(10H, m), 9.32(1H, s)

Example 16: Preparation of (/?)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy] propionic acid-λ'-(5-chloro-2-benzoxazolyI)-λ'-methyl amide

The procedure of Example 2 was repeated except for using (i?)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy]propionic acid-N-(5-chloro-2-benzoxazolyl)amide(0.45g, lmmol) obtained in Example 15 instead of (R)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-N-(5-chloro-2-benzoxazolyl)amide to obtain the title compound (302mg, 65 %). 1H-NMR(CDCl ₃ ) : δl .72(3H, d), 3.64(3H, s), 4.9O(1H, q), 6.88 ~ 7.56(1OH, m)

Example 17: Preparation of (/?)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy] propionic acid-iV-(l-methyl-2-benzimidazolyl)amide

The procedure of Example 15 was repeated except for using (R)-2-(4-hydroxyphenoxy)propionic acid-N-( 1 -methyl-2-benzimidazolyl)amide( 1.5g, 4.8mmol) obtained in Example (3-1) instead of (R)-2-(4-hydroxyphenoxy)propionic acid-N-(5-chloro-2-benzoxazolyl)amide to obtain the title compound (1.64g, 79.3 %). ¹ H-NMR(CDCl ₃ ) : δl.68(3H, d), 3.63(3H, s), 4.64(1H, q), 6.79~7.43(11H, m), 12.01(1H, s)

Example 18: Preparation of (l?)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy] propionic acid-7V-(l-methyl-2-benzimidazolyl)-7V-methyl amide

The procedure of Example 2 was repeated except for using (R)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy]propionic acid-N-(l-methyl-2-benzimidazolyl)amide(0.45g, lmmol) obtained in Example 17 instead of (^)-2- [4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic

acid-N-(5-chloro-2-benzoxazolyl)amide to obtain the title compound (302mg, 65 %). 1H-NMR(CDCl ₃ ) : δl.72(3H, d), 3.64(3H, s), 4.64(1H, q), 6.80 ~7.46(10H, m)

Example 19: Preparation of (/?)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy] propionic acid-7V-(2-benzothiazoIyl)amide

The procedure of Example 15 was repeated except for using (R)-2-(4-hydroxyphenoxy)propionic acid-N-(2-benzothiazolyl)amide(l .5g, 4.8mmol) obtained in Example (5-1) instead of (/?)-2-(4-hydroxyphenoxy)propionic acid-N-(5-chloro-2-benzoxazolyl)amide to obtain the title compound (1.75g, 84.1 %). 1H-NMR(CDCl ₃ ) : δl .68(3H, d), 4.87(1H, q), 6.73 -7.83(1 IH, m), 10.07(1H, s)

Example 20: Preparation of (U)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy] propionic acid-7V-(2-benzothiazolyl)-iV-methyl amide

The procedure of Example 2 was repeated except for using (R)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy]propionic acid-N-(2-benzothiazolyl)amide(0.44g, lmmol) obtained in Example 19 instead of (R)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-N-(5-chloro-2-benzoxazolyl)amide to obtain the title compound (322mg, 70.1 %). 1H-NMR(CDCl ₃ ) : δl.72(3H, d), 3.64(3H, s), 4.87(1H, q), 6.73 ~7.76(10H, m)

Example 21: Preparation of (/?)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy] propionic acid-7V-(6-chloro-2-benzothiazolyl)amide

The procedure of Example 15 was repeated except for using (7?)-2-(4-hydroxyphenoxy)propionic acid-N-(6-chloro-2-benzothiazolyl)amide( 1.67g, 4.8mmol) obtained in Example (7-1) instead of (R)-2-(4-hydroxyphenoxy)propionic acid-N-(5-chloro-2-benzoxazolyl)amide to obtain the title compound (1.6Og, 71.2 %). ¹ H-NMR(CDCl ₃ ) : δl.69(3H, d), 4.9O(1H, q), 6.85 ~7.79(10H, m), 9.76(1H, s)

Example 22: Preparation of (7?)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy] propionic acid-λ ^L (6-chloro-2-benzothiazolyl)-λ'-methyl amide

The procedure of Example 2 was repeated except for using (R)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy]propionic acid-N-(6-chloro-2-benzothiazolyl)amide(0.47g, lmmol) obtained in Example 21 instead of (R)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-N-(5-chloro-2-benzoxazolyl)amide to obtain the title compound (312mg, 64.3 %). 1H-NMR(CDCl ₃ ) : δl.69(3H, d), 3.65(3H, s), 4.9O(1H, q), 6.83 ~ 7.76(1OH, m)

Example 23: Preparation of (l?)-2-[4-(4-cyano-2-fIuorophenoxy)phenoxy] propionic acid-iV-(6-fluoro-2-benzothiazolyl)amide

The procedure of Example 15 was repeated except for using (R)-2-(4-hydroxyphenoxy)propionic acid-N-(6-fluoro-2-benzothiazolyl)amide(1.60g, 4.8mmol) obtained in Example (9-1) instead of (R)-2-(4-hydroxyphenoxy)propionic acid-N-(5-chloro-2-benzoxazolyl)amide to obtain the title compound (1.73g, 79.8 %). ¹ H-NMR(CDCl ₃ ) : δl .72(3H, d), 4.91(1H, q), 6.76 ~ 7.76(1OH, m), 9.88(1H, s)

Example 24: Preparation of (/?)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy] propionic acid-7V-(6-fluoro-2-benzothiazolyl)-λ'-methyl amide

The procedure of Example 2 was repeated except for using (R)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy]propionic acid-N-(6-fluoro-2-benzothiazolyl)amide(0.45g, lmmol) obtained in Example 23 instead. of (R)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-N-(5-chloro-2-benzoxazolyl)amide to obtain the title compound (300mg, 64.5 %). 1H-NMR(CDCl ₃ ) : δl .69(3H, d), 3.65(3H, s), 4.9O(1H, q), 6.73 ~7.76(10H, m)

Example 25: Preparation of (#)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy] propionic acid-iV-(6-methyl-2-benzothiazolyl)amide

The procedure of Example 15 was repeated except for using (R)-2-(4-hydroxyphenoxy)propionic acid-N-(6-methyl-2-benzothiazolyl)amide(1.58g, 4.8mmol) obtained in Example (11-1) instead of (R)-2-(4-hydroxyphenoxy)propionic acid-N-(5-chloro-2-benzoxazolyl)amide to obtain the title compound (1.9Og, 88.5 %). 1H-NMR(CDCl ₃ ) : δl.66(3H, d), 2.44(3H, s), 4.85(1H, q), 6.81 ~7.64(10H, m), 9.8O(1H, s)

Example 26: Preparation of (ft>2-[4-(4-cyano-2-fluorophenoxy)phenoxy] propionic acid-JV-(6-methyl-2-benzothiazolyl)-JV-methyl amide

The procedure of Example 2 was repeated except for using (R)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy]propionic acid-N-(6-methyl-2-benzothiazolyl)amide(0.45g, lmmol) obtained in Example 25 instead of (R)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-N-(5-chloro-2-benzoxazolyl)amide to obtain the title compound (307mg, 66 %). ¹ H-NMR(CDCl ₃ ) : δl.69(3H, d), 2.44(3H, s), 3.65(3H, s), 4.85(1H, q), 6.81 - 7.66(1OH, m)

Example 27: Preparation of (7?)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy] propionic acid-7V-(6-methoxy-2-benzothiazolyl)amide

The procedure of Example 15 was repeated except for using (R)-2-(4-hydroxyphenoxy)propionic acid-N-(6-methoxy-2-benzothiazolyl)amide(1.58g, 4.8mmol) obtained in Example (13-1) instead of (R)-2-(4-hydroxyphenoxy)propionic acid-N-(5-chloro-2-benzoxazolyl)amide to obtain the title compound (2.05g, 92.1 %). ¹ H-NMR(CDCl ₃ ) : δl.68(3H, d), 3.85(3H, s), 4.87(1H, q), 6.83 ~7.67(10H, m),

9.73(1H, s)

Example 28: Preparation of (/?)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy] propionic acid-λ^ό-methoxy^-benzothiazoly^-iV-methyl amide

The procedure of Example 2 was repeated except for using (i?)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy]propionic acid-N-(6-methoxy-2-benzothiazolyl)amide(0.46g, lmmol) obtained in Example 27 instead of (R)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-N-(5-chloro-2-benzoxazolyl)amide to obtain the title compound (333mg, 70 %). 1H-NMR(CDCl ₃ ) : δl.69(3H, d), 3.65(3H, s), 3.85(3H, s), 4.85(1H, q), 6.81 ~7.66(10H, m)

Example 29: Preparation of (U)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy] propionic acid-iV-(l ,3-dimethyl-5-pyrazolyl)amide

(29-1): (/?)-2-(4-hydroxyphenoxy)propionic acid-iV-(l,3-dimethyl-5-pyrazolyl) amide

The procedure of Example (1-1) was repeated except for using 5-amino-l,3-dimethylpyrazole(2.00g, 0.018mol) instead of

2-amino-5-chlorobenzoxazole to obtain the title compound (3.63g, 73.2 %). 1H-NMR(CDCl ₃ ) : δl.68(3H, d), 2.25(3H, s), 3.62(3H, s), 4.81(1H, q), 6.01(1H, s), 6.60~6.84(4H, m), 8.01(1H, s)

(29-2): (^)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy]propionic acid-iV-(l,3- dimethyl-5-pyrazolyl)amide

The procedure of Example 15 was repeated except for using (R)-2-(4-hydroxyphenoxy)propionic acid-7V-(l ,3-dimethyl-5-pyrazolyl)amide(l .32g, 4.8mmol) obtained in (29-1) instead of (R)-2-(4-hydroxyphenoxy)propionic acid-N-(5-chloro-2-benzoxazolyl)amide to obtain the title compound (1.65g, 87.2 %). ¹ H-NMR(CDCl ₃ ) : δl.68(3H, d), 2.21(3H, s), 3.59(3H, s), 4.81(1H, q), 6.07(1H, s),

6.87~7.49(7H, m), 7.98(1H, s)

Example 30: Preparation of (l?)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy] propionic acid-iV-(l,3-dimethyl-5-pyrazolyl)-λ ^r -methyl amide

The procedure of Example 2 was repeated except for using (R)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy]propionic acid-N-(l,3-dimethyl-5-pyrazolyl)amide(0.38g, lmmol) obtained in Example (29-2) instead of (R)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-N-(5-chloro-2-benzoxazolyl)amide to obtain the title compound (265mg, 67.1 %).

¹ H-NMR(CDCl ₃ ) : δl.68(3H, d), 2.21(3H, s), 3.59(3H, s), 3.65(3H, s), 4.81(1H, q), 6.07(1H, s), 6.87 ~7.49(7H, m)

Example 31: Preparation of (/?)-2-[4-(4-cyano-2-fluorophenoxy)phenoxyl propionic acid-/V-(2-thiazolyl)amide

(31-1): (/?)-2-(4-hydroxyphenoxy)propionic acid-7V-(2-thiazolyl)amide

The procedure of Example (1-1) was repeated except for using 2-aminothiazole(1.80g, 0.018mol) instead of 2-amino-5-chlorobenzoxazole to obtain the title compound (4.0g, 84.1 %). 1H-NMR(CDCl ₃ ) : δl.68(3H, d), 4.86(1H, q), 6.60 ~6.84(6H, m), 10.13(1H, s)

(31-2): (i?)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy]propionic acid-iV- (2-thiazolyl)amide

The procedure of Example 15 was repeated except for using (R)-2-(4-hydroxyphenoxy)propionic acid-N-(2-thiazolyl)amide(l .27g, 4.8mmol) obtained in Example (31-1) instead of (R)-2-(4-hydroxyphenoxy)propionic acid-N-(5-chloro-2-benzoxazolyl)amide to obtain the title compound (1.33g, 72.3 %). ¹ H-NMR(CDCl ₃ ) : δl.68(3H, d), 4.86(1H, q), 6.83 ~ 7.51(9H, m), 1O.13(1H, s)

Example 32: (i?)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy] propionic acid-JV-(2- thiazolyl)-iV-methyl amide

The procedure of Example 2 was repeated except for using (R)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy]propionic acid-N-(2-thiazolyl)amide(0.38g, lmmol) obtained in Example (31-2) instead of (i?)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-N-(5-chloro-2-benzoxazolyl)amide to obtain the title compound (249mg, 63 %). 1H-NMR(CDCl ₃ ) : δl.68(3H, d), 3.65(3H, s), 4.86(1H, q), 6.83 ~7.51(9H, m)

Example 33: Preparation of (if)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy] propionic acid-λ ^r -(4-methyl-2-pyridinyl)amide

(33-1) : (λ)-2-(4-hydroxyphenoxy)propionic acid-JV-(4-methyl-2-pyridinyl)amide

The procedure of Example (1-1) was repeated except for using 2-amino-4-methylpyridine(1.95g, 0.018mol) instead of 2-amino-5-chlorobenzoxazole to obtain the title compound (4.1g, 83.6 %).

¹ H-NMR(CDCl ₃ ) : δl.68(3H, d), 2.38(2H, s), 4.76(1H, q), 6.80~7.25(7H, m), 8.78(1H, s)

(33-2): (/?)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy]propionic acid-iV-(4- methyl-2-pyridinyl)amide

The procedure of Example 15 was repeated except for using (R)-2-(4-hydroxyphenoxy)propionic acid-N-(4-methyl-2-pyridinyl)amide(l .3 Ig,

4.8mmol) obtained in (33-1) instead of (R)-2-(4-hydroxyphenoxy)propionic acid-N-(5-chloro-2-benzoxazolyl)amide to obtain the title compound (1.29g, 68.7 %). ¹ H-NMR(CDCl ₃ ) : δl.68(3H, d), 2.38(2H, s), 4.76(1H, q), 6.83 ~ 8.15(10H, m), 8.78(1H, s)

Example 34: Preparation of (/?)-2-[4-(4-cyano-2-fIuorophenoxy)phenoxy] propionic acid-iV-(4-niethyl-2-pyridinyl)-7V-methyl amide

The procedure of Example 2 was repeated except for using (R)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy]propionic acid-N-(4-methyl-2-pyridinyl) amide(0.39g, lmmol) obtained in Example (33-2) instead of (R)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-N-(5-chloro-2-benzoxazolyl)amide to obtain the title compound (269mg, 66.4 %).

¹ H-NMR(CDCl ₃ ) : δl.68(3H, d), 2.38(2H, s), 3.65(3H, s), 4.76(1H, q), 6.83 ~8.15(10H, m)

Example 35: Preparation of (J?)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy] propionic acid-iV-(2-pyrazinyl)ainide

(35-1): (i?)-2-(4-hydroxyphenoxy)propionic acid-iV-(2-pyrazinyl)amide

The procedure of Example (1-1) was repeated except for using 2-aminopyrazine(1.71g, 0.018mol) instead of 2-amino-5-chlorobenzoxazole to obtain the title compound (4.1g, 87.9 %).

¹ H-NMR(CDCl ₃ ) : δl.70(3H, d), 4.83(1H, q), 6.67~ 8.24(7H, m), 8.8O(1H, s), 9.61(1H, s)

(35-2): (R)-2- [4-(4-cyano-2-fluorophenoxy)phenoxy] propionic acid-λ ^L (2- pyrazinyl)amide

The procedure of Example 15 was repeated except for using (R)-2-(4-hydroxyphenoxy)propionic acid-7V-(2-pyrazinyl)amide(l .25g, 4.8mmol) obtained in (35-1) instead of (R)-2-(4-hydroxyphenoxy)propionic acid-N-(5-chloro-2-benzoxazolyl)amide to obtain the title compound (1.34g, 73.8 %). ¹ H-NMR(CDCl ₃ ) : δl.70(3H, d), 4.83(1H, q), 6.87 ~ 8.40(1OH, m), 8.80(1H, s), 9.61(1H, s)

Example 36: Preparation of (i?)-2-[4-(4-cyano-2-fluoroplienoxy)phenoxy] propionic acid-7V-(2-pyrazinyl)-iV-methyl amide

The procedure of Example 2 was repeated except for using (i?)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy]propionic acid-N-(2-pyrazinyl)amide(0.38g, lmmol) obtained in Example (35-2) instead of (R)-2-[4-(6-chloro-2-benzoxazolyloxy)phenoxy]propionic acid-N-(5-chloro-2-benzoxazolyl)amide to obtain the title compound (239mg, 60.5 %). 1H-NMR(CDCl ₃ ) : δl.68(3H, d), 3.65(3H, s), 4.83(1H, q), 6.83 ~ 8.40(1OH, m)

Example 37: Preparation of (λ)-2-[4-(l-fluoro-2-phenylvinyloxy)phenoxy] propionic acid-λ^-(2-fluorophenyl)-λ ^r -methyl amide (1)

(37-1): difhiorostyrene

5.25g (0.02mol) of triphenyl phosphine was dissolved in 20ml of dichloromethane, and the mixture was cooled to 0 ^° C . 2.1g (O.Olmol) of dibromodifluoromethane was added to the mixture using an injector, and the reaction mixture was stirred for 30 minutes at room temperature. 1.06g (O.Olmol) of benzaldehyde was added thereto and the mixture was refluxed for 4 hours. The resulting mixture was distilled under a reduced pressure at 40 ^° C/lmmHg using a distilling apparatus to obtain the title compound (0.8 Ig, 57.5 %). 1H-NMR(CDCl ₃ ) : δ5.21(lH, s), 7.14~7.30(5H, m)

(37-2): (iS)-2-bromo-propionic acid-iV-(2-fluorophenyl)amide

A mixture of 6.8g (0.044mol) of (6)-2-bromopropionic acid and 5.33g (0.048mol) of 2-fluoroanyaniline was dissolved in 100ml of chloroform, and the mixture was cooled to 0 ^° C. 1Og (0.048mol) of dicyclohexylcarbodiamide dissolved in 20ml of chloroform was added to the reaction mixture using an injector, and the mixture was stirred at room temperature for 1 hour. The reaction mixture was filtered to remove unreacted solid therefrom and washed with 30ml of chloroform twice. The resulting residue was subjected to column chromatography (ethyl acetate: n-hexane = 1 : 3) to obtain the title compound (1Og, 86.1 %)

¹ H-NMR(CDCl ₃ ) : δl.7(3H, d), 4.16(1H, q), 7.13 ~7.48(4H, m)

(37-3): (2?)-2-(4-hydroxyphenoxy)propionic acid-λ^-(2-fluorophenyl)amide

A mixture of 17.2g (0.07mol) of the compound obtained in (37-2), 7g (0.064mol) of hydroquinone, 10.54g (0.076mol) of potassium carbonate and 1 g of tetra-n-butyl ammonium bromide was added in 300ml of acetonitrile, and the mixture was reflexed for 6 hours. The mixture was cooled to room temperature and filtered to remove unreacted solid therefrom, and the filtrate was distilled under a reduced pressure. The resulting residue was subjected to column chromatography (ethyl acetate: n-hexane = 1 : 2) to obtain the title compound (16g, 90.8 %). 1H-NMR(CDCl ₃ ) : δl.42(3H, d), 4.56(1H, q), 6.5 ~7.4(8H, m)

(37-4): (/?)-2-(4-hydroxyphenoxy)propionic acid-iV-(2-fluorophenyl)-iV -methylamide

5.8g (0.02mol) of the compound obtained in (37-3) was dissolved in anhydrous tetrahydrofuran, and the mixture was cooled to 0 ^° C . 0.8g (0.02mol) of 60% NaH and 2.8g (0.02mol) of methyliodide were sequentially added to the reaction mixture, and the mixture was stirred at room temperature for 5 hours. Ice was added to the reaction mixture and resulting mixture was extracted three times with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, filtered and distilled under a reduced pressure. The resulting residue was subjected to column chromatography (ethyl acetate: n-hexane = 1 : 2) to obtain the title compound (3.9 Ig, 67.6 %).

¹ H-NMR(CDCl ₃ ) : δl.47(3H, t), 3.29(3H, s), 4.63(1H, q), 5.63(1H, dd), 6.74~7.43(13H, m)

(37-5): (J?)-2-[4-(l-fluoro-2-phenylvinyloxy)phenoxy]propionic acid-7V-(2- fluorophenyl)-jV-methyl amide

A mixture of 5.8g (0.02mol) of the compound obtained in (37-4), 1.4g (0.02mol) of the compound obtained in Example (20-1) and 1.2g (0.02mol) of potassium carbonate was added in 100ml of acetonitrile, and the mixture was reflexed

for 7 hours. The resulting mixture was cooled to room temperature and filtered to remove unreacted solid therefrom, and the filtrate was distilled under a reduced pressure. The resulting residue was subjected to column chromatography (ethyl acetate: n-hexane = 1 : 4) to obtain the title compound (7.1g, 86.7 %) 1H-NMR(CDCl ₃ ) : δl.47(3H, t), 3.29(3H, s), 4.63(1H, q), 5.63(1H, dd), 6.74 ~ 7.43(13H, m)

Example 38: Preparation of (l?)-2-[4-(l-fluoro-2-phenylvinyloxy)phenoxy] propionic acid-iV-(2-fIuorophenyl) amide

The procedure of Example (37-5) was repeated except for using (R)-2-(4-hydroxyphenoxy)propionic acid-JV-(2-fluorophenyl)amide(5.5g, 0.02mol) obtained in Example (37-3) instead of (R)-2-(4-hydroxyphenoxy)propionic acid-N-(2-fluorophenyl)-N-methylamide to obtain the title compound (7.1 g, 89.8 %). ¹ H-NMR(CDCl ₃ ) : δl.47(3H, t), 4.62(1H, q), 5.63(1H, dd), 6.74~7.43(13H, m)

Example 37 : Preparation of (/?)-2-[4-(l-fluoro-2-phenylvinyIoxy)phenoxyJ propionic acid-N-(2-fiuorophenyl)-7V-methyl amide (2)

0.4g (lmmol) of the compound obtained in Example 38 was dissolved in anhydrous tetrahydrofuran, and the mixture was cooled to 0 ^° C . 40mg (lmmol) of 60% NaH and 0.14g (lmmol) of methyliodide were sequentially added to the reaction mixture, and the mixture was stirred at room temperature for 5 hours. Ice was added to the reaction mixture and resulting mixture was extracted three times with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, filtered and distilled under a reduced pressure. The resulting residue was subjected to column chromatography (ethyl acetate: n-hexane = 1 : 2) to obtain the title compound (300mg, 73.3 %).

¹ H-NMR(CDCl ₃ ) : δl.47(3H, t), 3.29(3H, s), 4.63(1H, q), 5.63(1H, dd), 6.74~ 7.43(13H, m)

Examples 39 to 44

The procedure of Example (37-5) was repeated except for using each of the corresponding styrene compound instead of difluorostyrene, and (R)-2-(4-hydroxyphenoxy)propionic acid-N-(2-fluorophenyl)amide obtained in Example (37-3) instead of (R)-2-(4-hydroxyphenoxy)propionic acid-N-(2-fiuorophenyl)-7V-methylamide to obtain the compounds shown in Table 2.

Table 2

Examples 45 to 50

The procedure of Example (37-5) was repeated except for using each of the corresponding styrene compound instead of difluorostyrene to obtain the compounds shown in Table 3.

Table 3

Examples 51 to 57

The procedure of Example (1-2) was repeated except for using each of the corresponding styrene compound instead of difluorostyrene to obtain the compounds shown in Table 4.

Table 4

Examples 58 to 64

The procedure of Example (37-4) was repeated except for using each of the compound obtained in Examples 58 to 64 instead of (R)-2-(4-hydroxyphenoxy)propionic acid-N-(2-fluorophenyl)amide to obtain the compounds shown in Table 5.

Table 5

Formulation Examples: Preparation of herbicidal formulations

Formulation Example 1: Wettable powders

Wettable powders were prepared by thoroughly mixing the following components while spraying the liquid surfactant onto the solid components. The resulting mixture was firstly ground in a hammer mill to obtain the powder having an average particle size of 100 μm or less and, then, secondly ground in an air mill to obtain the powder having an average particle size of 10 μm or less.

Compounds of any one of Examples 1 to 15, 20 and 22 to 34 : 20 % by weight Sodium lignin sulfonate: 4 % by weight

Sodium silicon aluminate : 6 % by weight Dodecylphenol polyethylene glycol ether : 2 % by weight Montmorillonite : 68 % by weight

Formulation Example 2: Water-dispersible granules

The procedure of Formulation Example 1 was repeated except for using the following components to obtain water-dispersible granules.

Compounds of any one of Examples 1 to 15, 20 and 22 to 34 : 20 % by weight Sodium naphthalene sulfonate : 10 % by weight Sodium dodecyl sulfate : 2 % by weight Dicalite : 15 % by weight Calcium carbonate : 53 % by weight

Formulation Example 3: Emulsions

Emulsions were prepared by mixing the following components, followed by homogeneously dissolving the mixture.

Compounds of any one of Examples 1 to 15, 20 and 22 to 34 : 20 % by weight Polyoxyethylene octylphenylether : 11 % by weight Calcium alkylbenzene sulfonate : 4 % by weight Cyclohexanone : 20 % by weight Methylnaphthalene : 45 % by weight

Formulation Example 4: Granules

Granules were prepared by mixing and grinding the following components, adding 18 to 20 parts by weight of water thereto based on the 100 parts by weight of the mixture, kneading the mixture, and granulating the resulting mixture to an average particle size of 14 to 32 meshes.

Compounds of any one of Examples 1 to 15, 20 and 22 to 34 : 5 % by weight

Sodium lignin sulfonate : 4 % by weight Carboxymethyl cellulose : 2 % by weight Sodium lauryl alcohol sulfate : 2 % by weight Postassium sulfate : 16 % by weight Calcium carbonate : 71 % by weight

Formulation Example 5: Microemulsions

Microemulsions were prepared by dissolving the following componensts in the organic solvent and adding 26 parts by weight of water thereto based on 100 parts by weight of the mixture to homogeneously dissolve the mixture.

Compound of any one of Examples 1 to 15, 20 and 22 to 34 : 20 % by weight polyoxyethylene glycol mono (tristyrylphenyl) ether : 12 % by weight polyoxy ethylene propylene glycol mono(tristyrylphenyl) ether : 12 % by weight glycol ether : 30 % by weight distilled water : 26 % by weight

Test Examples: Weed control test

Test Example 1

Seeds of rice, wheat, soy bean, barley, corn, common sorgum, barnyard grass, large crabgrass, creek grass, green foxtail and fall panicum were placed in sandy loam in 600 cm ² pots and covered with soil. After keeping the pots in a greenhouse at 20 to 30 °C allowing growth of the plants to the 3-leaf stage of the barnyard grass, 2,000 t/ha of an emulsion obtained by diluting with water a mixture of 1 part by weight of a test compound, 5 parts by weight of acetone and 1 part by weight of an emulsifying agent (Tween 80, Junsei) was applied to the surface of the foliage of the plants. The plant damage at 10 days and 20 days after the foliage treatment was visually evaluated from the level of 1 to 100% by comparison with the untreated control:

0% No herbicidal effect (identical to that of the control) 20% Slight herbicidal effect

70% Good herbicidal effect 90% Excellent herbicidal Effect 100% Full herbicidal effect (complete control of the weeds)

The plants used in the Test Examples are shown in Table 6, and the herbicidal activity of the test compounds are shown in Tables 7 and 8 in comparison with a known herbicide, phenoxaprop-P-ethyl (Bayer CropScience GmbH):

Table 6

Table 7

Test compound Treatment Dosage(kg/ha) (Example No.) Plant name

0.2 0.1 0.025

ZEAMX 100 100 40

GLXMA O 0 0

TRZAW O 0 0

ORYSA 5 5 0

SORBl 100 100 30

13 HORVU 5 5 0 i ECHOG 100 100 70

DIGSA 100 100 75

PANDI 100 100 20

λRTHJS 100 100 50

SETVIR 100 100 50

ZEAMX 90 10 0

GLXMA 0 0 0

TRZAW 0 0 0

ORYSA 0 0 0

SORBI 90 50 10

14 HORVU 70 0 0

ECHOG 70 20 0

DIGSA 70 20 0

PANDl 70 20 0

λRTHIS 50 20 0

I

SETVIR 50 20 0

ZEλMX 30 10 o !

GLXMA 0 0 0

TRZAW 0 0 0

ORYSA 0 0 0

SORBl 70 60 20

19 HOKVU 0 O 0

ECHOG 30 20 0

DlGSA 30 10 0

PANDI 0 0 0

ARTHIS 10 10 0

SETVIR 10 10 0

Test compound Treatment Dosage(kg/ha)

Plant name (Example No.) 0.2 0.1 0.025

ZEAMX 90 90 10

GLXMλ O 0 0

TRZAW O 0 0

ORYSA 20 0 0

SORBI 20 20 0

27 HORVU O 0 0

ECHOG 90 70 20

DICSA 90 20 0

PANDI 10 0 0

λRTHIS 10 0 0

SETVlR 20 0 0

ZEAMX 30 δ 0

GLXMA O 0 0

TRZAW O 0 0

ORYSA O 0 0

SORBI 50 20 0

29 HORVU O 0 0

ECHOG 90 70 20

DlGSA 90 20 0

I PANDI 10 0 0

ARTHIS 10 0 0

SETVIR 20 0 0

ZEAMX 90 90 20

GLXMλ 0 0 0

TR7.AW 0 0 0

ORYSA 0 0 0

SOKBI 50 20 0

: 3i HOKVU 0 0 0

I ECHOG 90 50 0

DIGSA 70 20 0

PANDI 20 20 0

ARTHlS 70 70 0

SETVIR 70 70 0

Test compound Treatment Dosage(kg/ha)

Plant name (Example No.) 0.2 0.1 0.025

ZEAMX 30 20 0

GLXMA 0 0 0

TRZAW 0 0 0 i ORYSλ 0 0 0

SORB] 80 65 20

35 HORVU 0 o

ECHOG 30 10 0

DIGSA 60 40 10

PANDl 30 0 0

1 t ARTHlS 30 10 0

SETVIR 50 30 0

ZEAMX 30 0 0

GLXMA 0 0 0

TRZAW 0 0 0

ORYSA 0 0 0

SORB) 20 20 0

37 HORVU 0 0 0

ECHOG 90 70 20

DlGSA 90 20 0

PANDI 10 0 0

ARTHIS 10 0 ϋ

SETVIR 20 0 0

I ZEAMX 100 100 90

GLXMA 0 0 0

TRZAW 0 0 0

ORYSA 0 0 0

SORBI 50 20 0

40 HO RVU 0 0 0

ECHOG 90 70 20

DIGSA 90 90 70

PANDI 10 0 0

ARTHIS 10 0 0

SETVlK 20 0 0

Table 8

As can be seen in Tables 7 and 8, the compounds prepared in the Examples exhibit high selectivity and safety for crop plants, while exhibiting excellent herbicidal activity against undesired weed grasses.

Test Example 2

Seeds of rice (Nampyung rice) and barnyard grasses (Echinochloa oryzicola and Echinochloa crus-galli var. crus-gallϊ) were placed in sandy loam of pots, covered with soil, and grown in the dry rice field conditions.

Rice (6 ~ 6.5-leaf stage, plant height 33.2 cm) and barnyard grasses {Echinochloa oryzicola: division stage 1~2, plant height 38.0 cm, Echinochloa crus-galli var. crus-galli : division stage 1~2, plant height 44.1cm) were subjected to a foliage treatment with emulsions prepared according to Formulation Example 3 by using compounds of Examples 1, 5 and 13 (purity: 99 % or more), wherein the emulsions were sprayed to the plants at a dosage of the active compound of 150g/ha.

The herbicidal effect on the barnyard grasses and harmful effect on the rice of

the test compounds at 20 days and 30 days after the foliage treatment were visually evaluated as in Test Example 1 in comparison with the untreated control, and the results are shown in Table 9.

Table 9

As can be seen in Table 9, the inventive (R)-aryloxypropionic acid amide compounds prepared in the Examples exhibit excellent herbicidal effects on Echinochloa oryzicola and Echinochloa crus-galli var. crus-galli at 20 days after the foliage treatment, as compared with the comparative compound, phenoxaprop-P-ethyl.